colorectal cancer

Showing NaN - NaN of 125

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Colorectal Cancer, Healthy Lifestyle, Behavior, Health Trial in Los Angeles (RISE Personalized Self-Managament Training (PSMT),

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • RISE Personalized Self-Managament Training (PSMT)
  • Standardized Self-Managament Training (SSMT)
  • Los Angeles, California
    Cedars-Sinai Medical Center
Aug 2, 2023

Advanced Solid Tumor, Colorectal Cancer Trial in Los Angeles (TORL-3-600)

Not yet recruiting
  • Advanced Solid Tumor
  • Colorectal Cancer
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Jul 20, 2023

Colorectal Cancer, Type 2 Diabetes Trial in Los Angeles (Intervention Group (IG))

Not yet recruiting
  • Colorectal Cancer
  • Type 2 Diabetes
  • Intervention Group (IG)
  • Los Angeles, California
    Charles R. Drew University
Mar 10, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Colorectal Cancer Screening in Cystic Fibrosis

Recruiting
  • Cystic Fibrosis
  • +2 more
  • Stool tests
  • Los Angeles, California
  • +24 more
Jan 26, 2023

Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +38 more
Jan 25, 2023

Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)

Active, not recruiting
  • Cutaneous Melanoma
  • +5 more
  • Birmingham, Alabama
  • +13 more
Jan 23, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Scottsdale, Arizona
  • +4 more
Dec 27, 2022

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

Completed
  • Non-small Cell Lung Cancer
  • +9 more
  • Little Rock, Arkansas
  • +32 more
Dec 12, 2022

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

Recruiting
  • Cancer
  • +21 more
  • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 7, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)

Active, not recruiting
  • Colorectal Cancer
  • Los Angeles, California
  • +12 more
Aug 19, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Colorectal Cancer, MSS, Stage IV Colon Cancer Trial in Belgium, Switzerland, United States (ATP128, BI 754091, VSV-GP128)

Recruiting
  • Colorectal Cancer
  • +5 more
  • Scottsdale, Arizona
  • +10 more
Aug 15, 2022

Colorectal Cancer, Colorectal Cancer Metastatic Trial in United States (Pembrolizumab, Regorafenib)

Active, not recruiting
  • Colorectal Cancer
  • Colorectal Cancer Metastatic
  • Duarte, California
  • +3 more
Aug 5, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Informed Choice - Compass

Recruiting
  • Colorectal Cancer
  • Brief Video
  • Brief Video Plus
  • Los Angeles, California
  • +5 more
Jul 29, 2022